S-1/A Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643

Filing Information

Form Type	S-1/A
Accession Number	`0001213900-19-020561`
Period End Date	20190630
Filing Date	20191017
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	rlmd-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 24 Cash Flow Statement 65 Stockholders Equity 20

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$7.62K	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$176.98K	USD	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$70.10K	USD	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$64.49K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$520.75K	USD	Point-in-time
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$426.92K	USD	Point-in-time
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$4.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.74M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.98M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$12.08K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$7.21K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$24.79K	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$273.24K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$203.14K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$3.05M	USD	Point-in-time
Total assets	`Assets`	$10.22M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.74M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.14M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.74M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.14M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.44K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$924.36K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$659.46K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.32M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$285.17K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$364.20K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.61M	USD	Point-in-time
Promissory notes payable, net of discount of $0 and $4,548,543	`LongTermNotesPayable`	-	USD	Point-in-time
Promissory notes payable, net of discount of $0 and $4,548,543	`LongTermNotesPayable`	$2.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.61M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.56M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 9,744,643 and 3,137,468 shares issued and outstanding, respectively	`CommonStockValue`	$9.74K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 9,744,643 and 3,137,468 shares issued and outstanding, respectively	`CommonStockValue`	$3.14K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.83M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$119.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-111.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-94.34M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$1.46M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$7.61M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$3.05M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$10.22M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.94M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$7.02M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.97M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.70M	USD	Annual
Total operating expenses	`OperatingExpenses`	$12.73M	USD	Annual
Total operating expenses	`OperatingExpenses`	$6.92M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-12.73M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-6.92M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-708.90K	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-54.63K	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-761.04K	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-1.34M	USD	Annual
Other	`OtherNonoperatingIncome`	-	USD	Annual
Other	`OtherNonoperatingIncome`	$2.35K	USD	Annual
Loss on Extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-3.77M	USD	Annual
Loss on Extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-4.59M	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-2.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.96M	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.86	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.74	USD	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.31M	shares	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.14M	shares	Annual

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.96M	USD	Annual
Depreciation expense	`Depreciation`	$2.63K	USD	Annual
Depreciation expense	`Depreciation`	$4.87K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$518.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.21M	USD	Annual
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	$661.17K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	$1.03M	USD	Annual
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$54.63K	USD	Annual
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$708.90K	USD	Annual
Fair value of shares relinquished	`FairValueOfSharesRelinquished`	$-394.41K	USD	Annual
Loss on promissory note extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-3.77M	USD	Annual
Loss on promissory note extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-42.74K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-270.17K	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-224.98K	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$169.36K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-59.32K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-64.49K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$157.39K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$158.92K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$215.63K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.18M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.50M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.00M	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	-	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$12.39K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.39K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	$6.53M	USD	Annual
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from sale of equity units, net of fees	`ProceedsFromIssuanceOrSaleOfEquity`	$17.76M	USD	Annual
Proceeds from sale of equity units, net of fees	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Payment on notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$8.50K	USD	Annual
Payment on notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-285.17K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.54M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.48M	USD	Annual
Net Increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$528.43K	USD	Annual
Net Increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$6.98M	USD	Annual
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Interest	`InterestPaidNet`	$2.56K	USD	Annual
Interest	`InterestPaidNet`	$5.93K	USD	Annual
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$364.20K	USD	Annual
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$285.17K	USD	Annual
Derivative liabilities associated with issuance of promissory notes	`DerivativeLiabilitiesOfPromissoryNotes`	-	USD	Annual
Derivative liabilities associated with issuance of promissory notes	`DerivativeLiabilitiesOfPromissoryNotes`	$3.31M	USD	Annual
Issuance of warrants to promissory notes payable placement agent	`IssuanceOfWarrants`	$200.66K	USD	Annual
Issuance of warrants to promissory notes payable placement agent	`IssuanceOfWarrants`	-	USD	Annual
Issuance of warrants to holders of promissory notes payable	`IssuanceOfWarrantsToHolders`	$1.27M	USD	Annual
Issuance of warrants to holders of promissory notes payable	`IssuanceOfWarrantsToHolders`	-	USD	Annual
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$100.00	USD	Annual
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$18.00	USD	Annual
Issuance of restricted stock for service	`IssuanceOfRestrictedStockForService`	$4.00	USD	Annual
Issuance of restricted stock for service	`IssuanceOfRestrictedStockForService`	-	USD	Annual
Write off for derivative liability due to adoption	`WriteOffForDerivativeLiabilityDueToAdoption`	-	USD	Annual
Write off for derivative liability due to adoption	`WriteOffForDerivativeLiabilityDueToAdoption`	$59.40K	USD	Annual
Conversion of promissory notes and accrued interest to common stock	`ConversionOfPromissoryNotesAndAccruedInterestToCommonStock`	-	USD	Annual
Conversion of promissory notes and accrued interest to common stock	`ConversionOfPromissoryNotesAndAccruedInterestToCommonStock`	$8.03M	USD	Annual

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time
Cumulative effect of Write-off of Derivative Liabilities under ASU 2017-11	`WriteoffOfSeriesDerivativeLiabilityForAdoptionValue`	$59.40K	USD	Annual
Adjusted Balance	`StockholdersEquityAdjustedBalances`	$-5.45M	USD	Annual
Issuance of restricted common stock	`StockIssuedDuringPeriodValueRestrictedStoc`	$4.00	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$1.21M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$518.00K	USD	Annual
Issuance of warrants to promissory notes payable placement agent	`IssuanceOfWarrantsToPromissoryNotesPayablePlacementAgent`	$200.66K	USD	Annual
Issuance of warrants to holders of promissory notes payable	`IssuanceOfWarrantsToHoldersOfPromissoryNotesPayable`	$1.27M	USD	Annual
Conversion of Notes and accrued interest	`StockIssuedDuringPeriodValueConversionOfUnits`	$11.80M	USD	Annual
Equity units issued for cash, net	`StockIssuedDuringPeriodValueOther`	$17.76M	USD	Annual
Shares relinquished by former officer	`SharesRelinquished`	$-394.41K	USD	Annual
Issuance of common stock for cashless exercises of warrants from consultants and Series A Preferred Stock warrant holder	`IssuanceOfCommonStockOnExerciseOfSeriesPreferredStockWarrants`	-	USD	Annual
Issuance of common stock for cashless exercises of warrants from consultants and Series A Preferred Stock warrant holder	`IssuanceOfCommonStockOnExerciseOfSeriesPreferredStockWarrants`	-	USD	Annual
Net loss	`ProfitLoss`	$-8.96M	USD	Annual
Net loss	`ProfitLoss`	$-17.32M	USD	Annual
Balance	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.